???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
José Manuel Sousa Lobo

Nomes de citação

  • Lobo, José

Identificadores de autor

Ciência ID
4111-8AF3-2FB6
ORCID iD
0000-0002-9518-8397
Formação
Grau Classificação
1989/07
Concluído
 Doutoramento em Farmácia - Especialidade Tecnologia Farmacêutica (Doutoramento)
Especialização em Especialidade de Tecnologia Farmacêutica
Universidade do Porto - Faculdade de Farmácia, Portugal
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2016 - 2018 Professor Catedrático (Docente Universitário) Universidade do Porto, Portugal
2016 - 2018 Professor Catedrático (Docente Universitário) Universidade do Porto, Portugal
2013 - 2016 Professor Catedrático (Docente Universitário) Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Professor Catedrático (Docente Universitário) Universidade do Porto Faculdade de Farmácia, Portugal
2014 - 2015 Professor Catedrático (Docente Universitário) Universidade do Porto Faculdade de Farmácia, Portugal
2014 - 2015 Professor Catedrático (Docente Universitário) Universidade do Porto Faculdade de Farmácia, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
2017 - 2022/01/01 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade do Porto, Portugal
2017 - 2018 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade do Porto, Portugal
2016 - 2018 Conselho científico/técnico-científico ou orgão correspondente Universidade do Porto, Portugal
2016 - 2018 Conselho de gestão ou orgão correspondente Universidade do Porto, Portugal
2016 - 2018 Conselho pedagógico Universidade do Porto, Portugal
2016 - 2018 Diretor ou presidente da unidade orgânica Universidade do Porto, Portugal
2016 - 2018 Conselho científico/técnico-científico ou orgão correspondente Universidade do Porto, Portugal
2016 - 2018 Conselho de gestão ou orgão correspondente Universidade do Porto, Portugal
2016 - 2018 Conselho pedagógico Universidade do Porto, Portugal
2016 - 2018 Diretor ou presidente da unidade orgânica Universidade do Porto, Portugal
2015 - 2016 Diretor ou presidente da unidade orgânica Universidade do Porto Faculdade de Farmácia, Portugal
2015 - 2016 Diretor ou presidente da unidade orgânica Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Conselho científico/técnico-científico ou orgão correspondente Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Conselho geral ou orgão correspondente Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Conselho pedagógico Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Conselho científico/técnico-científico ou orgão correspondente Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Conselho geral ou orgão correspondente Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Conselho pedagógico Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2016 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade do Porto Faculdade de Farmácia, Portugal
Projetos

Bolsa

Designação Financiadores
2007/07 - 2010/12 PROBIOCAPS - tailored microencaPsulation technology foR prOBIOtic baCteriA: Production, stability and functionality enhancementS in various carriers
grant.Provided by PTCRIS: 71051
 Fundação para a Ciência e a Tecnologia
Produções

Publicações

Artigo em conferência
  1. Lobo, José. "Application of the quality by design (QdB) approach to improve the nose-to-brain delivery of diazepam-loaded nanostructured lipid carriers (NLC)". Trabalho apresentado em 1st international electronic conference on pharmaceutics, 2020.
  2. Cunha, Sara; Forbes, Ben; Sousa Lobo, José; Silva, Ana. "Thermosensitive nasal in situ gels of lipid-based nanosystems to improve the treatment of Alzheimer's disease". Trabalho apresentado em the 1st international electronic conference on pharmaceutics, 2020.
    10.3390/iecp2020-08648
Artigo em revista
  1. Sandra Mota; Cláudia Pinto; Sara Cravo; Joana Rocha e Silva; Carlos Afonso; José Manuel Sousa Lobo; Maria Elizabeth Tiritan; Honorina Cidade; Isabel Filipa Almeida. "Quercus suber: A Promising Sustainable Raw Material for Cosmetic Application". Applied Sciences 12 9 (2022): 4604-4604. https://doi.org/10.3390/app12094604.
    10.3390/app12094604
  2. Diana I. S. P. Resende; Ana Jesus; José M. Sousa Lobo; Emília Sousa; Maria T. Cruz; Honorina Cidade; Isabel F. Almeida. "Up-to-Date Overview of the Use of Natural Ingredients in Sunscreens". Pharmaceuticals (2022): https://doi.org/10.3390/ph15030372.
    10.3390/ph15030372
  3. Rita Sanches Oliveira; Diva Ferraz da Silva; Sandra Mota; Jorge Garrido; Ermelinda Manuela Garrido; J. M. Sousa Lobo; Isabel Almeida. "Design of an Emulgel for Psoriasis Focused on Patient Preferences". Applied Sciences (2022): https://www.mdpi.com/2076-3417/12/7/3260.
    10.3390/app12073260
  4. Ana Jesus; Emília Sousa; Maria Cruz; Honorina Cidade; José Lobo; Isabel Almeida. "UV Filters: Challenges and Prospects". Pharmaceuticals 15 3 (2022): 263-263. https://doi.org/10.3390/ph15030263.
    10.3390/ph15030263
  5. Marta S. Ferreira; José M. Sousa Lobo; Isabel F. Almeida. "Sensitive skin: Active ingredients on the spotlight". International Journal of Cosmetic Science (2022): https://doi.org/10.1111/ics.12754.
    10.1111/ics.12754
  6. Diana I. S. P. Resende; Marta Salvador Ferreira; J. M. Sousa Lobo; E Sousa; Isabel Almeida. "Skin Depigmenting Agents in Anti-Aging Cosmetics: A Medicinal Perspective on Emerging Ingredients". Applied Sciences (2022): https://www.mdpi.com/2076-3417/12/2/775.
    10.3390/app12020775
  7. Brandon Aguiar; Carmo H; Jorge Garrido; J. M. Sousa Lobo; Isabel Almeida. "In Vitro Evaluation of the Photoreactivity and Phototoxicity of Natural Polyphenol Antioxidants". Molecules (2021): https://www.mdpi.com/1420-3049/27/1/189.
    10.3390/molecules27010189
  8. Ana Teixeira; Maribel Teixeira; Vera Almeida; Rita Gaio; Tiago Torres; Sofia Magina; Cátia Cunha; J. M. Sousa Lobo; Isabel Almeida. "Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis". Pharmaceutics (2021): https://www.mdpi.com/1999-4923/13/10/1539.
    10.3390/pharmaceutics13101539
  9. Marta Salvador Ferreira; Diana I. S. P. Resende; J. M. Sousa Lobo; E Sousa; Isabel Almeida. "Marine Ingredients for Sensitive Skin: Market Overview". Marine Drugs (2021): https://www.mdpi.com/1660-3397/19/8/464.
    10.3390/md19080464
  10. Diana I. S. P. Resende; Marta Salvador Ferreira; J. M. Sousa Lobo; E Sousa; Isabel Almeida. "Usage of Synthetic Peptides in Cosmetics for Sensitive Skin". Pharmaceuticals (2021): https://www.mdpi.com/1424-8247/14/8/702.
    10.3390/ph14080702
  11. Cláudia Pina Costa; Sandra Barreiro; Moreira JN; Renata Silva; H Almeida; J. M. Sousa Lobo; Ana Catarina Silva. "In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)". Pharmaceuticals (2021): https://www.mdpi.com/1424-8247/14/8/711.
    10.3390/ph14080711
  12. Marta Salvador Ferreira; Maria Catarina Magalhães; Rita Oliveira; J. M. Sousa Lobo; Isabel Almeida. "Trends in the Use of Botanicals in Anti-Aging Cosmetics". Molecules (2021): https://www.mdpi.com/1420-3049/26/12/3584.
    10.3390/molecules26123584
  13. Lobo, José. "Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review". Nanomedicine: Nanotechnology, Biology and Medicine 28 (2020): 102206-102206. http://dx.doi.org/10.1016/j.nano.2020.102206.
    10.1016/j.nano.2020.102206
  14. Lobo, José. "Development of a Platform to Align Education and Practice: Bridging Academia and the Profession in Portugal". Pharmacy 8 1 (2020): 11-11. http://dx.doi.org/10.3390/pharmacy8010011.
    10.3390/pharmacy8010011
  15. Lobo, José. "Patient centric pharmaceutical drug product design: the impact on medication adherence". Pharmaceutics (2020):
  16. Lobo, José. "Biotechnology applied to cosmetics and aesthetic medicines". cosmetics (2020):
  17. Lobo, José. "Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by design (QbD) approach: formulation variables and instrumental parameters". Pharmaceutics 13 4 (2020):
  18. Lobo, José. "Efficacy, stability and safety evaluation of new polyphenolic xanthones towards identification of bioactive compounds to fight skin photoaging". Molecules 25 12 (2020):
  19. Lobo, José. "Pessaries containing nanostructured lipid carriers (NLC) for prolonged vaginal delivery of progesterone". European journal of pharmaceutics and biopharmaceutics 153 (2020):
  20. Lobo, José. "Alginate microparticles as carriers for the UV filter 2-ethylhexyl 4-methoxycinnamate: Influence on photostability". International Journal of Cosmetic Science 41 6 (2019): 585-593. http://dx.doi.org/10.1111/ics.12578.
    10.1111/ics.12578
  21. Lobo, José. "Implementation of an in vitro methodology for phototoxicity evaluation in a human keratinocyte cell line". Toxicology in Vitro 61 (2019): 104618-104618. http://dx.doi.org/10.1016/j.tiv.2019.104618.
    10.1016/j.tiv.2019.104618
  22. Lobo, José. "Hydroxypropyl-ß-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing". Carbohydrate Polymers 221 (2019): 55-62. http://dx.doi.org/10.1016/j.carbpol.2019.05.084.
    10.1016/j.carbpol.2019.05.084
  23. Lobo, José. "Evolution of the use of antioxidants in anti-ageing cosmetics". International Journal of Cosmetic Science (2019): http://dx.doi.org/10.1111/ics.12551.
    10.1111/ics.12551
  24. Lobo, José. "Evaluation of the biocompatibility and skin hydration potential of vitamin E-loaded lipid nanosystems formulations: In vitro and human in vivo studies.". Colloids and surfaces. B, Biointerfaces (2019): https://doi.org/10.1016/j.colsurfb.2019.03.036.
    10.1016/j.colsurfb.2019.03.036
  25. Lobo, José. "Mechanical Properties of Topical Anti-Psoriatic Medicines: Implications for Patient Satisfaction with Treatment.". AAPS PharmSciTech (2019): https://doi.org/10.1208/s12249-018-1246-2.
    10.1208/s12249-018-1246-2
  26. Lobo, José. "Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis.". Journal of controlled release : official journal of the Controlled Release Society (2019): https://doi.org/10.1016/j.jconrel.2018.12.049.
    10.1016/j.jconrel.2018.12.049
  27. Lobo, José. "Patient preferences for attributes of topical anti-psoriatic medicines.". The Journal of dermatological treatment (2018): https://doi.org/10.1080/09546634.2018.1544410.
    10.1080/09546634.2018.1544410
  28. Lobo, José. "Biosimilar medicines used for cancer therapy in Europe: a review.". Drug discovery today (2018): https://doi.org/10.1016/j.drudis.2018.09.011.
    10.1016/j.drudis.2018.09.011
  29. Lobo, José. "Hydroxypropyl-ß-Cyclodextrin and ß-Cyclodextrin as Tablet Fillers for Direct Compression.". AAPS PharmSciTech (2018): https://doi.org/10.1208/s12249-018-1115-z.
    10.1208/s12249-018-1115-z
  30. Lobo, José. "Cyclodextrins as excipients in tablet formulations". (2018): http://dx.doi.org/10.1016/j.drudis.2018.04.009.
    10.1016/j.drudis.2018.04.009
  31. Lobo, José. "Photostabilization strategies of photosensitive drugs". International Journal of Pharmaceutics (2018): http://dx.doi.org/10.1016/j.ijpharm.2018.02.012.
    10.1016/j.ijpharm.2018.02.012
  32. Lobo, José. "SULFATION PATHWAYS: Potential benefits of a sulfated resveratrol derivative for topical application.". Journal of molecular endocrinology (2018): https://doi.org/10.1530/JME-18-0031.
    10.1530/jme-18-0031
  33. Lobo, José. "Intranasal Lipid Nanoparticles for the Treatment of Neurodegenerative Diseases". (2018): http://dx.doi.org/10.2174/1381612824666171128105305.
    10.2174/1381612824666171128105305
  34. Lobo, José. "Editorial: Applications of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): State of the Art". (2018): http://dx.doi.org/10.2174/138161282343180215151302.
    10.2174/138161282343180215151302
  35. Lobo, José. "Cyclodextrins as Drug Carriers in Pharmaceutical Technology: The State of the Art.". Current pharmaceutical design (2018): https://doi.org/10.2174/1381612824666171218125431.
    10.2174/1381612824666171218125431
  36. Garcês, A.; Amaral, M.H.; Sousa Lobo, J.M.; Silva, A.C.. "Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review". European Journal of Pharmaceutical Sciences 112 (2018): 159-167. http://www.scopus.com/inward/record.url?eid=2-s2.0-85035792792&partnerID=MN8TOARS.
    10.1016/j.ejps.2017.11.023
  37. Lobo, José. "Editorial: Applications of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): State of the Art.". Current pharmaceutical design (2017): https://doi.org/10.2174/1381612824666171214102607.
    10.2174/1381612824666171214102607
  38. Lobo, José. "Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen". (2017): http://dx.doi.org/10.1016/j.ijpharm.2017.04.025.
    10.1016/j.ijpharm.2017.04.025
  39. Lobo, José. "Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP)". (2017): http://dx.doi.org/10.1007/s40257-017-0272-2.
    10.1007/s40257-017-0272-2
  40. Lobo, José. "Characterization and biocompatibility evaluation of cutaneous formulations containing lipid nanoparticles". (2017): http://dx.doi.org/10.1016/j.ijpharm.2017.01.045.
    10.1016/j.ijpharm.2017.01.045
  41. Lobo, José. "In silico and in vitro antioxidant and cytotoxicity evaluation of oxygenated xanthone derivatives". (2017): http://dx.doi.org/10.1016/j.arabjc.2017.01.006.
    10.1016/j.arabjc.2017.01.006
  42. Rocha, V.; Marques, C.; Figueiredo, J.L.; Gaio, A.R.; Costa, P.C.; Sousa Lobo, J.M.; Almeida, I.F.. "In vitro cytotoxicity evaluation of resveratrol-loaded nanoparticles: Focus on the challenges of in vitro methodologies". Food and Chemical Toxicology 103 (2017): 214-222. http://www.scopus.com/inward/record.url?eid=2-s2.0-85015416193&partnerID=MN8TOARS.
    10.1016/j.fct.2017.03.017
  43. Almeida, H.; Lobão, P.; Frigerio, C.; Fonseca, J.; Silva, R.; Sousa Lobo, J.M.; Amaral, M.H.. "Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen". Pharmaceutical Development and Technology 22 3 (2017): 336-349. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951283674&partnerID=MN8TOARS.
    10.3109/10837450.2015.1125922
  44. Cunha, S.; Amaral, M.H.; Sousa Lobo, J.M.; Silva, A.C.. "Lipid nanoparticles for nasal/intranasal drug delivery". Critical Reviews in Therapeutic Drug Carrier Systems 34 3 (2017): 257-282. http://www.scopus.com/inward/record.url?eid=2-s2.0-85022204722&partnerID=MN8TOARS.
    10.1615/CritRevTherDrugCarrierSyst.2017018693
  45. Lobo, José. "Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems". (2016): http://dx.doi.org/10.2174/0929867323666160824162401.
    10.2174/0929867323666160824162401
  46. Lobo, José. "Development of mucoadhesive and thermosensitive eyedrops to improve the ophthalmic bioavailability of ibuprofen". (2016): http://dx.doi.org/10.1016/j.jddst.2016.04.010.
    10.1016/j.jddst.2016.04.010
  47. Moreno, M.; Amaral, M.H.; Sousa Lobo, J.M.; Silva, A.C.. "Scaffolds for bone regeneration: State of the art". Current Pharmaceutical Design 22 18 (2016): 2726-2736. http://www.scopus.com/inward/record.url?eid=2-s2.0-84974686116&partnerID=MN8TOARS.
    10.2174/1381612822666160203114902
  48. Teixeira, A.; Teixeira, M.; Almeida, V.; Torres, T.; Sousa Lobo, J.M.; Almeida, I.F.. "Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment". Journal of Dermatological Science 82 2 (2016): 63-68. http://www.scopus.com/inward/record.url?eid=2-s2.0-84963614516&partnerID=MN8TOARS.
    10.1016/j.jdermsci.2016.02.008
  49. Estanqueiro, M.; Amaral, M.H.; Sousa Lobo, J.M.. "Comparison between sensory and instrumental characterization of topical formulations: impact of thickening agents". International Journal of Cosmetic Science 38 4 (2016): 389-398. http://www.scopus.com/inward/record.url?eid=2-s2.0-84978254032&partnerID=MN8TOARS.
    10.1111/ics.12302
  50. Almeida, H.; Lobão, P.; Frigerio, C.; Fonseca, J.; Silva, R.; Palmeira-de-Oliveira, A.; Sousa Lobo, J.M.; Amaral, M.H.. "New thermoresponsive eyedrop formulation containing ibuprofen loaded-nanostructured lipid carriers (NLC): Development, characterization and biocompatibility studies". Current Drug Delivery 13 6 (2016): 953-970. http://www.scopus.com/inward/record.url?eid=2-s2.0-84983800184&partnerID=MN8TOARS.
  51. Lobo, José. "Main Benefits and Applicability of Plant Extracts in Skin Care Products". (2015): http://dx.doi.org/10.3390/cosmetics2020048.
    10.3390/cosmetics2020048
  52. Lobo, José. "Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles.". Current pharmaceutical biotechnology (2015): https://doi.org/10.2174/1389201016666150731112532.
    10.2174/1389201016666150731112532
  53. Lobo, José. "Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers.". Current pharmaceutical biotechnology (2015): https://doi.org/10.2174/1389201016666150817094637.
    10.2174/1389201016666150817094637
  54. Lobo, José. "Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists.". Current drug metabolism (2015): https://doi.org/10.2174/1389200216666150401110211.
    10.2174/1389200216666150401110211
  55. Lobo, José. "Lipid nanoparticles for the delivery of biopharmaceuticals.". Current pharmaceutical biotechnology (2015): https://doi.org/10.2174/1389201015666141229103709.
    10.2174/1389201015666141229103709
  56. Lobo, José. "Editorial: New Trends in Pharmaceutical Nanotechnology.". Current pharmaceutical design (2015): https://doi.org/10.2174/1381612821999150929095516.
    10.2174/1381612821999150929095516
  57. Lobo, José. "EDITORIAL: Advances in Pharmaceutical Biotechnology.". Current pharmaceutical biotechnology (2015): https://doi.org/10.2174/1389201016999150827103855.
    10.2174/1389201016999150827103855
  58. Lobo, José. "Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.". Current pharmaceutical design (2015): https://doi.org/10.2174/1381612821666150923095155.
    10.2174/1381612821666150923095155
  59. Almeida, I.F.; Pinto, A.S.; Monteiro, C.; Monteiro, H.; Belo, L.; Fernandes, J.; Bento, A.R.; et al. "Protective effect of C. sativa leaf extract against UV mediated-DNA damage in a human keratinocyte cell line". Journal of Photochemistry and Photobiology B: Biology 144 (2015): 28-34. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922791203&partnerID=MN8TOARS.
    10.1016/j.jphotobiol.2015.01.010
  60. Estanqueiro, M.; Amaral, M.H.; Conceição, J.; Sousa Lobo, J.M.. "Nanotechnological carriers for cancer chemotherapy: The state of the art". Colloids and Surfaces B: Biointerfaces 126 (2015): 631-648. http://www.scopus.com/inward/record.url?eid=2-s2.0-84923065229&partnerID=MN8TOARS.
    10.1016/j.colsurfb.2014.12.041
  61. Lobo, José. "Technological Excipients of Tablets: Study of Flow Properties and Compaction Behavior". (2014): http://dx.doi.org/10.12691/ajmsm-2-4-2.
    10.12691/ajmsm-2-4-2
  62. Lobo, José. "Characterization, sensorial evaluation and moisturizing efficacy of nanolipidgel formulations.". International journal of cosmetic science (2014): https://doi.org/10.1111/ics.12109.
    10.1111/ics.12109
  63. Lobo, José. "Characterization and stability studies of emulsion systems containing pumice". (2014): http://dx.doi.org/10.1590/s1984-82502014000200016.
    10.1590/s1984-82502014000200016
  64. Lobo, José. "In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations". (2014): http://dx.doi.org/10.1016/j.drudis.2013.10.001.
    10.1016/j.drudis.2013.10.001
  65. Lobo, José. "Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations.". Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques (2014):
  66. Estanqueiro, M.; Conceição, J.; Amaral, M.H.; Manuel Sousa Lobo, J.. "Use of solid dispersions to increase stability of dithranol in topical formulations". Brazilian Journal of Pharmaceutical Sciences 50 3 (2014): 583-590. http://www.scopus.com/inward/record.url?eid=2-s2.0-84911437013&partnerID=MN8TOARS.
    10.1590/S1984-82502014000300018
  67. Afonso, S.; Horita, K.; Sousa E Silva, J.P.; Almeida, I.F.; Amaral, M.H.; Lobão, P.A.; Costa, P.C.; et al. "Photodegradation of avobenzone: Stabilization effect of antioxidants". Journal of Photochemistry and Photobiology B: Biology 140 (2014): 36-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905247944&partnerID=MN8TOARS.
    10.1016/j.jphotobiol.2014.07.004
  68. Tichota, D.M.; Silva, A.C.; Sousa Lobo, J.M.; Amaral, M.H.. "Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration". International Journal of Nanomedicine 9 1 (2014): 3855-3864. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905962794&partnerID=MN8TOARS.
    10.2147/IJN.S64008
  69. Lobo, José. "Bacterial cellulose membranes as drug delivery systems: an in vivo skin compatibility study.". European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (2013): https://doi.org/10.1016/j.ejpb.2013.08.008.
    10.1016/j.ejpb.2013.08.008
  70. Santos, A.J.M.; Crista, D.M.A.; Miranda, M.S.; Almeida, I.F.; Sousa E Silva, J.P.; Costa, P.C.; Amaral, M.H.; et al. "Degradation of UV filters 2-ethylhexyl-4-methoxycinnamate and 4-tert-butyl-4'-methoxydibenzoylmethane in chlorinated water". Environmental Chemistry 10 2 (2013): 127-134. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878575143&partnerID=MN8TOARS.
    10.1071/EN13012
  71. E Silva, J.P.S.; Splendor, D.; Gonçalves, I.M.B.; Costa, P.; Sousa Lobo, J.M.. "Note on the measurement of bulk density and tapped density of powders according to the European pharmacopeia". AAPS PharmSciTech 14 3 (2013): 1098-1100. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890152920&partnerID=MN8TOARS.
    10.1208/s12249-013-9994-5
  72. Almeida, H.; Amaral, M.H.; Lobão, P.; Sousa Lobo, J.M.. "Applications of poloxamers in ophthalmic pharmaceutical formulations: An overview". Expert Opinion on Drug Delivery 10 9 (2013): 1223-1237. http://www.scopus.com/inward/record.url?eid=2-s2.0-84882404475&partnerID=MN8TOARS.
    10.1517/17425247.2013.796360
  73. Almeida, H.; Amaral, M.H.; Lobão, P.; Sousa Lobo, J.M.. "Influence of drug incorporation, temperature and storage time on the pH, textural and rheological properties of different poloxamer hydrogels". Current Drug Delivery 10 6 (2013): 753-764. http://www.scopus.com/inward/record.url?eid=2-s2.0-84889072376&partnerID=MN8TOARS.
    10.2174/15672018113109990056
  74. Silva, A.C.; González-Mira, E.; Sousa Lobo, J.M.; Amaral, M.H.. "Current progresses on nanodelivery systems for the treatment of neuropsychiatric diseases: Alzheimer's and schizophrenia". Current Pharmaceutical Design 19 41 (2013): 7185-7195. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890941075&partnerID=MN8TOARS.
    10.2174/138161281941131219123329
  75. Rodrigues, D.; Rocha-Santos, T.; Sousa, S.; Gomes, A.M.; Pintado, M.M.; Xavier Malcata, F.; Sousa Lobo, J.M.; et al. "On the viability of five probiotic strains when immobilised on various polymers". International Journal of Dairy Technology 64 1 (2011): 137-144. http://www.scopus.com/inward/record.url?eid=2-s2.0-78751617228&partnerID=MN8TOARS.
    10.1111/j.1471-0307.2010.00627.x
  76. Rodrigues, D.; Sousa, S.; Rocha-Santos, T.; Silva, J.P.; Sousa Lobo, J.M.; Costa, P.; Amaral, M.H.; et al. "Influence of l-cysteine, oxygen and relative humidity upon survival throughout storage of probiotic bacteria in whey protein-based microcapsules". International Dairy Journal 21 11 (2011): 869-876. http://www.scopus.com/inward/record.url?eid=2-s2.0-80051590355&partnerID=MN8TOARS.
    10.1016/j.idairyj.2011.05.005
  77. Sousa E Silva, J.P.; Sousa Lobo, J.M.. "Compatibility studies between nebicapone, a novel COMT inhibitor, and excipients using stepwise isothermal high sensitivity DSC method". Journal of Thermal Analysis and Calorimetry 102 1 (2010): 317-321. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650016717&partnerID=MN8TOARS.
    10.1007/s10973-010-0807-8
  78. Lopes, C.M.; Sousa Lobo, J.M.; Pinto, J.F.; Costa, P.C.. "Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen". AAPS PharmSciTech 8 3 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-35148838685&partnerID=MN8TOARS.
    10.1208/pt0803051
  79. Costa, P.; Sousa Lobo, J.M.. "Evaluation of mathematical models describing drug release from estradiol transdermal systems". Drug Development and Industrial Pharmacy 29 1 (2003): 89-97. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037273037&partnerID=MN8TOARS.
    10.1081/DDC-120016687
  80. Amaral, M.H.; Sousa Lobo, J.M.; Ferreira, D.C.. "Effect of water-soluble carriers on naproxen release from hydrophilic matrix tablets". S.T.P. Pharma Sciences 13 3 (2003): 191-194. http://www.scopus.com/inward/record.url?eid=2-s2.0-0042369033&partnerID=MN8TOARS.
  81. Ferreira, D.; Sarmento, B.; Amaral, H.; Veiga, F.; Sousa Lobo, J.M.. "Design and development of oral controlled release microcapsules containing naproxen". Anales de la Real Academia de Farmacia 69 1 (2003): 145-155. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037530618&partnerID=MN8TOARS.
  82. Amaral, M.H.; Sousa Lobo, J.M.; Ferreira, D.C.. "Naproxen availability from variable-dose and weight sustained-release tablets". Drug Development and Industrial Pharmacy 27 3 (2001): 221-225. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035083517&partnerID=MN8TOARS.
    10.1081/DDC-100000240
  83. Costa, P.; Sousa Lobo, J.M.. "Modeling and comparison of dissolution profiles". European Journal of Pharmaceutical Sciences 13 2 (2001): 123-133. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035073301&partnerID=MN8TOARS.
    10.1016/S0928-0987(01)00095-1
  84. Costa, P.; Sousa Lobo, J.M.. "Divisability of diltiazem matrix sustained-release tablets". Pharmaceutical Development and Technology 6 3 (2001): 343-351. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034923485&partnerID=MN8TOARS.
    10.1081/PDT-100002616
  85. Amaral, M.H.; Sousa Lobo, J.M.; Ferreira, D.C.. "Effect of hydroxypropyl methycellulose and hydrogenated castor oil on naproxen release from sustained-release tablets". AAPS PharmSciTech 2 2 (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-10644273849&partnerID=MN8TOARS.
  86. Costa, P.; Amaral, H.; Sousa Lobo, J.M.. "Dissolution characteristics of divisible tablets". S.T.P. Pharma Sciences 10 5 (2000): 373-377. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033775662&partnerID=MN8TOARS.
  87. Costa, P.; Sousa Lobo, J.M.. "Avaliação das características de libertação de fármacos a partir de formas sólidas". Revista Portuguesa de Farmacia 50 1 (2000): 41-50. http://www.scopus.com/inward/record.url?eid=2-s2.0-0039923566&partnerID=MN8TOARS.
  88. Ribeiro, A.J.; Arnaud, P.; Sousa Lobo, J.M.; Chaumeil, J.C.; Neufeld, R.J.. "Sustained release of organosulfur compounds from microencapsulated oily garlic extracts". Proceedings of the Controlled Release Society 26 (1999): 955-956. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032732687&partnerID=MN8TOARS.
  89. Ferreira, D.C.; Costa, P.; Morgado, R.; Sousa Lobo, J.M.. "Evaluation of an in vitro dissolution and permeation apparatus for oral solid pharmaceutical dosage forms". Drug Development and Industrial Pharmacy 23 4 (1997): 387-392. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030901193&partnerID=MN8TOARS.
  90. Costa, P.; Ferreira, D.C.; Morgado, R.; Sousa Lobo, J.M.. "Design and evaluation of a lorazepam transdermal delivery system". Drug Development and Industrial Pharmacy 23 10 (1997): 939-944. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030851035&partnerID=MN8TOARS.
  91. Lima, C.M.; Costa, P.; Ferreira, D.C.; Sousa Lobo, J.M.. "Comprimidos de dipirona obtidos por diferentes processos de granulação: Estudo comparativo das velocidades de dissolução e permeação in-vitro". Revista Portuguesa de Farmacia 47 3 (1997): 95-100. http://www.scopus.com/inward/record.url?eid=2-s2.0-0345846982&partnerID=MN8TOARS.
  92. Ferreira, D.C.; Costa, P.; Sousa Lobo, J.M.. "Effect of pH on the release and permeation of diazepam from sustained-release dosage forms". Pharmaceutical Sciences 3 4 (1997): 171-173. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031416595&partnerID=MN8TOARS.
  93. Costa, P.; Ferreira, D.C.; Sousa Lobo, J.M.. "Determination of drug release profiles of nitroglycerin transdermal therapeutic systems | NITROGLICERINA EM SISTEMAS DE LIBERTACAO TRANSDERMICA - DETERMINACAO DA VELOCIDADE DE LIBERTACAO". Revista Portuguesa de Farmacia 46 1 (1996): 4-8. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029988883&partnerID=MN8TOARS.
  94. Costa, P.; Ferreira, D.C.; Sousa Lobo, J.M.. "Nitroglicerina em Sistemas de Libertação Transdérmica - Determinação da velocidade de libertação". Revista Portuguesa de Farmacia 46 1 (1996): 2-8. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542786133&partnerID=MN8TOARS.
  95. Lobo, José. "Sustained-Release Tablet Containing Oxazepam: Study and Design". Drug Development and Industrial Pharmacy (1995): http://dx.doi.org/10.3109/03639049509048125.
    10.3109/03639049509048125
  96. Costa, P.; Ferreira, D.C.; Sousa Lobo, J.M.. "Lorazepam in the transdermal releasing system. Selection and study of plasticizers | LORAZEPAM EM SISTEMAS DE LIBERTACAO TRANSDERMICA - SELECCAO E ESTUDO DO PLASTIFICANTE". Revista Portuguesa de Farmacia 45 2 (1995): 84-88. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029070335&partnerID=MN8TOARS.
  97. Costa, P.; Ferreira, D.C.; Sousa Lobo, J.M.. "Lorazepam in the transdermal releasing system. Influence of agitation, temperature and thickness of the film on the release of lorazepam 'in vitro' | LORAZEPAM EM SISTEMAS DE LIBERTACAO TRANSDERMICA. INFLUENCIA DA AGITACAO, DA TEMPERATURA E DA ESPESSURA DA PELICULA NA CEDENCIA IN VITRO DE LORAZEPAM". Revista Portuguesa de Farmacia 45 2 (1995): 79-83. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029034377&partnerID=MN8TOARS.
  98. Duru, C.; Gaudy, D.; Sousa Lobo, J.M.; Bataille, B.; Jacob, M.; Puech, A.. "A comparison of the lyoavailability of the active ingredient in tablets obtained with classic grains and with extruded/spheronized grains | LYODISPONIBILITE COMPAREE DU PRINCIPE ACTIF DE COMPRIMES OBTENUS A PARTIR DE GRAINS CLASSIQUES ET DE GRAINS EXTRUDES/SPHERONISES". S.T.P. Pharma Sciences 4 3 (1994): 226-229. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028359923&partnerID=MN8TOARS.
  99. Carvalho Ferreira, D.; Nogueira Prista, L.V.; Ramos Morgado, R.M.; Sousa Lobo, J.M.. "Rectal absorption of oxazepam from suppositories in rabbits | ESTUDO DA ABSORCAO RECTAL DO OXAZEPAM EM COELHOS". Anales de la Real Academia de Farmacia 60 4 (1994): 675-687. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028649533&partnerID=MN8TOARS.
  100. Duru, C.; Sousa-Lobo, J.M.; Bataille, B.; Gaudy, D.; Jacob, M.; Puech, A.. "Extrusion/spheronization and grain tablettability | EXTRUSION/SPHERONISATION ET COMPRIMABILITE DU GRAIN". S.T.P. Pharma Sciences 3 2 (1993): 136-141. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027157034&partnerID=MN8TOARS.
  101. Costa, P.; Ferreira, D.C.; Sousa Lobo, J.M.. "Transdermal drug delivery systems | SISTEMAS DE LIBERTACAO TRANSDERMICA". Revista Portuguesa de Farmacia 43 3 (1993): 19-26. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027504869&partnerID=MN8TOARS.
  102. Carvalho Ferreira, D.; Nogueira Prista, L.V.; Ramos Morgado, R.M.; Sousa Lobo, J.M.. "The stability of lorazepam solutions: II. The influence of solvents | ESTABILIDADE DO LORAZEPAM EM SOLUCOES AQUOSAS: II. INFLUENCIA DO SOLVENTE". Revista Portuguesa de Farmacia 42 2 (1992): 19-22. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026714925&partnerID=MN8TOARS.
  103. Dos Santos, E.R.; Prista, L.V.N.; Sousa Lobo, J.M.; Santos, D.G.. "Study on the cutaneous penetration of lapachol. I. In vitro assay | ESTUDOS DE DIFUSAO CUTANEA DO LAPACHOL. I. ENSAIOS 'IN VITRO'". Revista Portuguesa de Farmacia 41 3 (1991): 15-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-0025792318&partnerID=MN8TOARS.
Capítulo de livro
  1. Lobo, José. "Cytokines and Growth Factors". 87-113. Springer International Publishing, 2019.
    10.1007/10_2019_105
  2. Lobo, José. "Hormones, blood products, and therapeutic enzymes". In Current applications of pharmaceutical biotechnology. 2019.
  3. Lobo, José. "Delivering miRNA modulators for cancer treatment". 2018.
    10.1016/b978-0-12-813689-8.00014-8
  4. Lobo, José. "Lipid-Based Nanocarriers in Cancer Therapy". 2017.
    10.1016/b978-0-323-52725-5.00004-6
Edição de livro
  1. Lobo, José. Current applications of pharmaceutical biotechnology. 2019.
Livro
  1. Estanqueiro, M.; Conceição, J.; Amaral, M.H.; Sousa Lobo, J.M.. The role of liposomes and lipid nanoparticles in the skin hydration. 2016.
    10.1016/B978-0-323-42868-2.00012-7
  2. Santos Silva, I.; Palma, C.; Lemos, F.; Ramôa Ribeiro, F.; Sousa Lobo, J.. Non-catalytic carbon gasification modelling. 1997.
Distinções

Título

2023 Professor Emérito da Universidade do Porto